Φορτώνει......
Comparative Effectiveness of Infliximab and Adalimumab for Crohn’s Disease
BACKGROUND & AIMS: Antibodies against tumor necrosis factor-α (anti-TNF) are widely used in the treatment of Crohn’s disease (CD). This study compared the effectiveness of infliximab and adalimumab, the two most commonly used anti-TNF medications for CD. METHODS: We conducted a retrospective coh...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , , , , , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2013
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3883891/ https://ncbi.nlm.nih.gov/pubmed/23811254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2013.06.010 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|